A PAINKILLER taken by millions [...].
Findings from a large study in the US showed that ibuprofen, widely marketed in the UK as Nurofen, lowered the risk of developing Parkinson's disease by as much as 38%.
Other pain-relieving medicines, such as aspirin, naproxen and diclofenac, did not have the same effect.
Researchers believe ibuprofen may have a unique ability to protect the brain cells that are lost by Parkinson's patients.
The scientists analysed data from more than 37,000 male health professionals and almost 99,000 female nurses.
Participants' use of pain-relieving medicines known as nonsteroidal anti-Inflammatory drugs (NSAIDS) was recorded along with other information such as age, smoking habits, and diet.
The results showed that those who took ibuprofen two or more times a week were 38% less likely to develop Parkinson's than those who did not.
|Printer friendly Cite/link Email Feedback|
|Publication:||Evening Chronicle (Newcastle, England)|
|Date:||Mar 7, 2011|
|Previous Article:||Bringing home the dangers of regular drinking; Health Reporter HELEN RAE takes a look at a campaign that is encouraging people in the North East to...|
|Next Article:||A MISCARRIAGE can cause depression [...].|